Should induction chemotherapy be considered for all patients with gastric cancer?
An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.
Hickish
T F
TF
CRC Section of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
Cunningham
D
D
D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D006801:Humans; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery